The Buprenorphine Market in 2023 is US$ 5.51 billion, and is expected to reach US$ 17.1 billion by 2031 at a CAGR of 15.20%.
FutureWise Research published a report that analyzes Buprenorphine Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and...
The Buprenorphine Market comprises products such as sublingual tablets, buccal films, implants and injections that are used for the treatment of opioid addiction and pain management. Buprenorphine is a partial opioid agonist that helps in controlling opioid cravings and reducing the associated risks of opioid dependence. It provides an alternative to methadone for patients diagnosed with opioid...
The Buprenorphine Market comprises products such as sublingual tablets, buccal films, implants and injections that are used for the treatment of opioid addiction and pain management. Buprenorphine is a partial opioid agonist that helps in controlling opioid cravings and reducing the associated risks of opioid dependence. It provides an alternative to methadone for patients diagnosed with opioid...
Buprenorphine is an opioid medication primarily used to treat opioid use disorder, acute pain, and chronic pain. It is typically taken under the tongue as a film, tablet, or as an injection. Buprenorphine helps to relieve cravings and withdrawal symptoms associated with opioid addiction. The medication works by activating opioid receptors in the brain to relieve pain and reduce opioid cravings...